Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance

被引:1
|
作者
Botha, Johannes C. [1 ,2 ]
Byott, Matthew [1 ,2 ]
Spyer, Moira J. [1 ,2 ]
Grant, Paul R. [3 ]
Gaertner, Kathleen [1 ]
Chen, Wilson X. [4 ]
Burton, James [5 ]
Bamford, Alasdair [1 ,5 ,6 ]
Waters, Laura J. [7 ]
Giaquinto, Carlo [8 ,9 ]
Turkova, Anna [5 ,6 ]
Vavro, Cindy L. [4 ]
Nastouli, Eleni [1 ,2 ]
机构
[1] UCL, Great Ormond St Inst Child Hlth, London WC1N 1EH, England
[2] Univ Coll London Hosp NHS Trust, Adv Pathogen Diagnost Unit, London NW1 2PG, England
[3] Hlth Serv Labs, London WC1H 9AX, England
[4] ViiV Healthcare, Durham, NC 27709 USA
[5] Great Ormond St Hosp Children NHS Fdn Trust, London WC1N 3JH, England
[6] UCL, Med Res Council, Clin Trials Unit, London WC1E 6BT, England
[7] Cent & North West London NHS Fdn Trust, Mortimer Market, London WC1E 6JB, England
[8] Univ Padua, Dept Women & Child Hlth, I-35122 Padua, Italy
[9] Fdn Penta ETS, I-35127 Padua, Italy
来源
VIRUSES-BASEL | 2023年 / 15卷 / 09期
基金
芬兰科学院; 英国医学研究理事会;
关键词
HIV-1; DNA; drug resistance; provirus; NGS; sanger; BLOOD; DIVERSITY; RESERVOIR; THERAPY; ASSAY;
D O I
10.3390/v15091811
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Modern HIV-1 treatment effectively suppresses viral amplification in people living with HIV. However, the persistence of HIV-1 DNA as proviruses integrated into the human genome remains the main barrier to achieving a cure. Next-generation sequencing (NGS) offers increased sensitivity for characterising archived drug resistance mutations (DRMs) in HIV-1 DNA for improved treatment options. In this study, we present an ultra-sensitive targeted PCR assay coupled with NGS and a robust pipeline to characterise HIV-1 DNA DRMs from buffy coat samples. Our evaluation supports the use of this assay for Pan-HIV-1 analyses with reliable detection of DRMs across the HIV-1 Pol region. We propose this assay as a new valuable tool for monitoring archived HIV-1 drug resistance in virologically suppressed individuals, especially in clinical trials investigating novel therapeutic approaches.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Sensitive HIV-1 DNA pol next generation sequencing (NGS) for the characterisation of archived antiretroviral drug resistance
    Botha, J. C.
    Byott, M.
    Spyer, M. J.
    Gartner, K.
    Grant, P. R.
    Chen, W. X.
    Burton, J.
    Bamford, A.
    Giaquinto, C.
    Turkova, A.
    Vavro, C. L.
    Nastouli, E.
    [J]. HIV MEDICINE, 2023, 24 : 354 - 355
  • [2] HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance
    Anna Maria Geretti
    Jose Luis Blanco
    Anne Genevieve Marcelin
    Carlo Federico Perno
    Hans Jurgen Stellbrink
    Dan Turner
    Tuba Zengin
    [J]. Infectious Diseases and Therapy, 2022, 11 : 1793 - 1803
  • [3] HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance
    Geretti, Anna Maria
    Blanco, Jose Luis
    Marcelin, Anne Genevieve
    Perno, Carlo Federico
    Stellbrink, Hans Jurgen
    Turner, Dan
    Zengin, Tuba
    [J]. INFECTIOUS DISEASES AND THERAPY, 2022, 11 (05) : 1793 - 1803
  • [4] Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA
    Tumiotto, Camille
    Riviere, Lionel
    Bellecave, Pantxika
    Recordon-Pinson, Patricia
    Vilain-Parce, Alice
    Guidicelli, Gwenda-Line
    Fleury, Herve
    [J]. PLOS ONE, 2017, 12 (09):
  • [5] Towards Next-Generation Sequencing for HIV-1 Drug Resistance Testing in a Clinical Setting
    Teo, Calesta Hui Yi
    Norhisham, Nurul Hannah Binte
    Lee, Ogestelli Fabia
    Png, Siyu
    Chai, Chean Nee
    Yan, Gabriel
    Tang, Julian Wei-Tze
    Lee, Chun Kiat
    [J]. VIRUSES-BASEL, 2022, 14 (10):
  • [6] Routine drug resistance testing in HIV-1 proviral DNA, using an automated next-generation sequencing assay
    Alidjinou, Enagnon Kazali
    Coulon, Pauline
    Hallaert, Christophe
    Robineau, Olivier
    Meybeck, Agnes
    Huleux, Thomas
    Ajana, Faiza
    Hober, Didier
    Bocket, Laurence
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2019, 121
  • [7] Next-generation sequencing and HIV drug resistance surveillance
    Hamers, Raph L.
    Paredes, Roger
    [J]. LANCET HIV, 2016, 3 (12): : E553 - E554
  • [8] Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal
    Pimentel, Victor
    Pingarilho, Marta
    Sebastiao, Cruz S.
    Miranda, Mafalda
    Goncalves, Fatima
    Cabanas, Joaquim
    Costa, Ines
    Diogo, Isabel
    Fernandes, Sandra
    Costa, Olga
    Corte-Real, Rita
    Martins, M. Rosario O.
    Seabra, Sofia G.
    Abecasis, Ana B.
    Gomes, Perpetua
    [J]. VIRUSES-BASEL, 2024, 16 (04):
  • [9] RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients
    Alidjinou, E. K.
    Deldalle, J.
    Hallaert, C.
    Robineau, O.
    Ajana, F.
    Choisy, P.
    Hober, D.
    Bocket, L.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (10) : 2823 - 2830
  • [10] HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform
    Gholami, Mohammad
    Rouzbahani, NeginHosseini
    Samiee, SiamakMirab
    Tayeri, Katayoun
    Ghorban, Khodayar
    Dehkharghani, Alireza Dolatyar
    Gholami, Ali Akbar
    Moshiri, Farzaneh
    Sattari, Arash
    Dadmanesh, Maryam
    Mohraz, Minoo
    [J]. MICROBIAL PATHOGENESIS, 2020, 146